Ashish Upadhyay, MD

Associate Professor, Medicine

Ashish Upadhyay
Renal Section, Evans Biomedical Research Building – 650 Albany Street, Suite 5A

Biography

Dr. Upadhyay is a board-certified nephrologist with academic interests in examining the mechanisms of cardiovascular disease in patients with chronic kidney disease (CKD), hemodialysis systems, and evidence-based medicine (EBM). He has conducted epidemiologic research in the Framingham Heart Study, led the evidence review team for the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on lipid management in CKD, and participated in the evidence review teams for the KDIGO clinical practice guidelines on blood pressure management in CKD and anemia management in CKD. He maintains an active clinical practice in general nephrology, hemodialysis, and peritoneal dialysis, and is the Program Director of BU’s Nephrology Fellowship Training Program. In addition, he directs research and EBM curriculum of BU’s Internal Medicine Residency Program, and was an Associate Program Director of the Internal Medicine Residency Program from 2012 to 2018. Outside of BU, Dr. Upadhyay serves as a voting member of the Association for the Advancement of Medical Instrumentation (AAMI)’s Renal Disease and Detoxification Committee, the primary source of national and international consensus standards for hemodialysis technology and dialysis water sterilization processes.

Other Positions

  • Program Director, Nephrology Fellowship Program, Boston University School of Medicine
  • Director, Scholarship and EBM, Internal Medicine Residency Program, Boston University School of Medicine

Education

  • Tribhuvan University, MBBS

Publications

  • Published on 3/8/2018

    Toth PP, Dwyer JP, Cannon CP, Colhoun HM, Rader DJ, Upadhyay A, Louie MJ, Koren A, Letierce A, Mandel J, Banach M. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. Kidney Int. 2018 06; 93(6):1397-1408. PMID: 29526502.

    Read at: PubMed
  • Published on 6/13/2017

    Upadhyay A, Susantitaphong P, Jaber BL. Ultrapure versus standard dialysate: A cost-benefit analysis. Semin Dial. 2017 09; 30(5):398-402. PMID: 28608933.

    Read at: PubMed
  • Published on 3/1/2017

    Chen C, Upadhyay A. Renal denervation for uncontrolled hypertension: critical review of the evidence. Curr Opin Nephrol Hypertens. 2017 Mar; 26(2):114-122. PMID: 27922849.

    Read at: PubMed
  • Published on 1/8/2017

    Upadhyay A, Jaber BL. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant? Semin Dial. 2017 Mar; 30(2):121-124. PMID: 28066932.

    Read at: PubMed
  • Published on 4/8/2016

    Upadhyay A, Jaber BL. We Use Impure Water to Make Dialysate for Hemodialysis. Semin Dial. 2016 Jul; 29(4):297-9. PMID: 27061684.

    Read at: PubMed
  • Published on 4/1/2016

    Stillman MD, Miller KH, Ziegler CH, Upadhyay A, Mitchell CK. Program Characteristics Influencing Allopathic Students' Residency Selection. J Am Osteopath Assoc. 2016 Apr; 116(4):214-26. PMID: 27018956.

    Read at: PubMed
  • Published on 11/1/2015

    Upadhyay A, Inker LA, Levey AS. Chronic Kidney Disease: Definition, Classification and Approach to Management. Goldsmith D, Section editor. Oxford Textbook of Clinical Nephrology. Oxford University Press. Oxford, UK. 2015; 743-754.

  • Published on 4/1/2015

    Wang K, Upadhyay A. Sugar-sweetened Beverages and Chronic Kidney Disease. US Endocrinology. 2015; 1(11):41-45; DOI: 10.17925/USE.2015.

    Read at: Custom
  • Published on 10/25/2013

    Upadhyay A. Statins in chronic kidney disease: what do meta-analyses tell us? Clin Exp Nephrol. 2014 Apr; 18(2):278-81. PMID: 24158229.

    Read at: PubMed
  • Published on 10/4/2013

    Roseman DA, Hwang SJ, Manders ES, O'Donnell CJ, Upadhyay A, Hoffmann U, Fox CS. Renal artery calcium, cardiovascular risk factors, and indexes of renal function. Am J Cardiol. 2014 Jan 1; 113(1):156-61. PMID: 24210678.

    Read at: PubMed

View 24 more publications: View full profile at BUMC

View all profiles